These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27019321)

  • 1. Reducing ICD Test Shocks with a Simplified Upper Limit of Vulnerability.
    Pittaro M; Deforge W; Kroll MW
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):652-7. PubMed ID: 27019321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic determination of timing intervals for upper limit of vulnerability using ICD electrograms.
    Shehata M; Belk P; Kremers M; Saba S; Cao J; Swerdlow CD
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):691-700. PubMed ID: 18507541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test.
    Patel MB; Pandya K; Thakur RK
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated vulnerability testing identifies patients with inadequate defibrillation safety margin.
    Birgersdotter-Green U; Ruetz LL; Anand K; Monir G; Abeyratne AI; Bailey JR; Shorofsky SR; Hsia HH; Friedman PA
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1073-80. PubMed ID: 23051838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The zone of vulnerability to T wave shocks in humans.
    Swerdlow CD; Martin DJ; Kass RM; Davie S; Mandel WJ; Gang ES; Chen PS
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):145-54. PubMed ID: 9147699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-tilt monophasic and biphasic waveforms compared with standard biphasic waveforms in the transvenous defibrillation of ventricular fibrillation.
    Bennett JR; Darragh KM; Walsh SJ; Allen DJ; Scott M; Stevenson M; Adgey JA; Anderson JM; Manoharan G
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):279-89. PubMed ID: 24102186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
    Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
    Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
    J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans.
    Hwang C; Swerdlow CD; Kass RM; Gang ES; Mandel WJ; Peter CT; Chen PS
    Circulation; 1994 Nov; 90(5):2308-14. PubMed ID: 7955188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation.
    Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of the upper limit of vulnerability is different for monophasic and biphasic shocks: implications for the determination of the defibrillation threshold.
    Behrens S; Li C; Franz MR
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2179-87. PubMed ID: 9309741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.